Table 2.

Evolution of HbA1C levels percentages of time in range (TIR) 3.9–10 mmol/L (70–180 mg/dl) and coefficient of variation of glucose values between baseline at M0 and after 3 months of insulin pump therapy with sensor-augmented pumps (SAP) or Hybrid Closed Loop (HCL) systems

	SAP (n = 85)	HCL (n = 36)	p
HbA1C MO, mean (± SEM) % mmol/mol	8.04 (± 0.11) 64.56 (± 1.10)	7.70 (± 0.11) 60.69 (± 1.2)	0.31
HbA1C M3, mean (± SEM) % mmol/mol	7.66 (± 0.1) 60.54 (± 0.94)	6.84 (± 0.05) 51.24 (± 0.61)	< 0.001
TIR M0, mean (± SEM)	49.8 (± 1.75)	54.4 (± 1.75)	0.2
TIR M3, mean (± SEM)	53.5 (± 1.88)	75.6 (± 1.2)	< 0.001
CV M0, mean (± SEM)	41.0 (± 7.27)	37.7 (± 1.17)	0.031
CV M3, mean (± SEM)	39.8 (± 7.35)	34.1 (± 0.63)	< 0.001